Collegium Pharmaceutical sells prescription medicines for ADHD and pain in the United States. It last closed at $25.55 on Nov 17, up 0.47% on the day. The average 12-month price target from 6 analysts is $42.83 (+67.6% from the last close), with a high of $50.00 and a low of $28.00. Analyst consensus is Strong Buy, based on the latest ratings from 6 firms (5 buy, 1 hold, 0 sell).
Each firm's latest rating on COLL in the past 90 days
Average 12-month target
$42.83
▲ 67.6% upside
Based on 6 analysts who set a price target on COLL in the past 90 days. The average target is $42.83, with a high of $50.00 and a low of $28.00, compared with the last close of $25.55.
Low $28.00Avg $42.83High $50.00
Blue marker: last close $25.55
Highest target$50.00
Average target$42.83
Lowest target$28.00
Latest rating changes
BarclaysTarget lowered
Nov 16Buy$48 → $41
Piper SandlerTarget lowered
Nov 6Hold$43 → $28
NeedhamTarget lowered
Nov 5Buy$46 → $44
OppenheimerInitiated
Sep 23Buy$50
Truist SecuritiesMaintained
Sep 9Buy$49
Date
Firm
Action
Rating
Price target
Nov 16
Barclays
Target lowered
Buy
$48 → $41
Nov 6
Piper Sandler
Target lowered
Hold
$43 → $28
Nov 5
Needham
Target lowered
Buy
$46 → $44
Sep 23
Oppenheimer
Initiated
Buy
$50
Sep 9
Truist Securities
Maintained
Buy
$49
Loading…
Technical Analysis
COLL · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend, nearing overbought
The stock is 6% above its 20 day and 10% above its 50 day average. It is 25% below its 200 day average, so the longer trend is down. Momentum is strong (RSI 66), near overbought. The nearest support is the swing low (Aug 12) at $25.47, and the nearest resistance the Pivot R1 at $25.81.
Short trendBullish
Long trendBearish
MomentumStrong
StretchNear overbought
VolatilityNormal, 3.5%/day
Key levels
$50.7952 week high+98.8%
$31.95200 day average+25.0%
$27.35100 day average+7.0%
$26.39Swing high (Nov 5)+3.3%
$25.81Pivot R1+1.0%
$25.55Last close
$25.47Swing low (Aug 12)−0.3%
$25.41Pivot−0.5%
$25.15Pivot S1−1.6%
$24.1220 day average−5.6%
$23.1250 day average−9.5%
$21.4352 week low−16.1%
Indicators
RSI (14)
65.73
Strong, overbought above 70
Neutral
MACD
0.58
Above its signal line
Bullish
Stochastic
72.9
Middle of its range
Neutral
ADX (14)
27.1
Trending up
Williams %R
-26.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
120.5
Oversold below −100, overbought above 100
Overbought
Rate of change
+7.7%
Change over 10 sessions
Bullish
ATR (14)
$0.88
Typical daily range, 3.5% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumNeutral
StretchNormal
VolatilityNormal, 9.8%/day
Key levels
$50.7952 week high+98.8%
$31.95200 day average+25.0%
$27.35100 day average+7.0%
$26.39Swing high (Nov 5)+3.3%
$25.81Pivot R1+1.0%
$25.55Last close
$25.47Swing low (Aug 12)−0.3%
$25.41Pivot−0.5%
$25.15Pivot S1−1.6%
$24.1220 day average−5.6%
$23.1250 day average−9.5%
$21.4352 week low−16.1%
Indicators
RSI (14)
41.20
Middle of its range
Neutral
MACD
-2.81
Above its signal line
Bullish
Stochastic
38.6
Middle of its range
Neutral
ADX (14)
25.8
Trending down
Williams %R
-49.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
-23.2
Oversold below −100, overbought above 100
Neutral
Rate of change
+12.3%
Change over 10 sessions
Bullish
ATR (14)
$2.50
Typical daily range, 9.8% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for COLL
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how COLL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow COLL usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How COLL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether COLL is in one of them and how their past COLL trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Collegium Pharmaceutical
Collegium Pharmaceutical is a biopharmaceutical company based in Stoughton, Massachusetts. It sells prescription medicines in the United States for attention deficit hyperactivity disorder and for moderate to severe pain. Its products include Jornay PM for ADHD, Belbuca, Xtampza ER and the Nucynta products for pain, and Symproic for constipation caused by opioid use. Its customers are patients who receive these medicines through prescriptions written by doctors.